| 0 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
319 |
0.0032 |
| 1 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
1 |
0.0019 |
| 2 |
CTLA-4-directed Blocking Antibody [EPC] |
74 |
0.0015 |
| 3 |
Programmed Death Ligand-1 Blocker [EPC] |
24 |
0.0011 |
| 4 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
4 |
0.0005 |
| 5 |
Lipid Emulsion [EPC] |
1 |
0.0004 |
| 6 |
Platinum-based Drug [EPC] |
99 |
0.0004 |
| 7 |
Orexin Receptor Antagonist [EPC] |
6 |
0.0003 |
| 8 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
2 |
0.0003 |
| 9 |
Bile Acid [EPC] |
6 |
0.0003 |
| 10 |
Microtubule Inhibitor [EPC] |
36 |
0.0002 |
| 11 |
Chloride Channel Activator [EPC] |
2 |
0.0002 |
| 12 |
alpha-Glucosidase Inhibitor [EPC] |
1 |
0.0002 |
| 13 |
Antimalarial [EPC] |
2 |
0.0002 |
| 14 |
Antiprotozoal [EPC] |
2 |
0.0002 |
| 15 |
Somatostatin Analog [EPC] |
1 |
0.0001 |
| 16 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
8 |
0.0001 |
| 17 |
Aluminum Complex [EPC] |
3 |
0.0001 |
| 18 |
Glinide [EPC] |
1 |
0.0001 |
| 19 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 20 |
Aromatase Inhibitor [EPC] |
7 |
0.0001 |
| 21 |
Prostaglandin E1 Analog [EPC] |
1 |
0.0001 |
| 22 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
11 |
0.0001 |
| 23 |
Antimetabolite Immunosuppressant [EPC] |
1 |
0.0000 |
| 24 |
Kinase Inhibitor [EPC] |
25 |
0.0000 |
| 25 |
Nucleoside Metabolic Inhibitor [EPC] |
12 |
0.0000 |
| 26 |
Folate Analog Metabolic Inhibitor [EPC] |
19 |
0.0000 |
| 27 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 28 |
Dihydropyridine Calcium Channel Blocker [EPC] |
13 |
0.0000 |
| 29 |
Factor Xa Inhibitor [EPC] |
8 |
0.0000 |
| 30 |
Androgen Receptor Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
Angiotensin 2 Receptor Blocker [EPC] |
8 |
0.0000 |
| 32 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
3 |
0.0000 |
| 33 |
alpha-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 34 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
27 |
0.0000 |
| 35 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Ester Local Anesthetic [EPC] |
1 |
0.0000 |
| 37 |
Proton Pump Inhibitor [EPC] |
11 |
0.0000 |
| 38 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 39 |
Vitamin B12 [EPC] |
6 |
0.0000 |
| 40 |
P2Y12 Platelet Inhibitor [EPC] |
2 |
0.0000 |
| 41 |
Corticosteroid [EPC] |
21 |
0.0000 |
| 42 |
Fluoroquinolone Antibacterial [EPC] |
2 |
0.0000 |
| 43 |
Histamine-2 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 44 |
RANK Ligand Inhibitor [EPC] |
3 |
0.0000 |
| 45 |
Opioid Agonist [EPC] |
4 |
0.0000 |
| 46 |
Osmotic Laxative [EPC] |
4 |
0.0000 |
| 47 |
Vitamin D [EPC] |
4 |
0.0000 |
| 48 |
Benzodiazepine [EPC] |
9 |
0.0000 |
| 49 |
Non-Standardized Chemical Allergen [EPC] |
1 |
0.0000 |
| 50 |
Integrin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 51 |
Amide Local Anesthetic [EPC] |
1 |
0.0000 |
| 52 |
Serotonin Reuptake Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 55 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 56 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 57 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 58 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 59 |
Vitamin C [EPC] |
4 |
0.0000 |
| 60 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 61 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 62 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 63 |
Platelet Aggregation Inhibitor [EPC] |
4 |
0.0000 |
| 64 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 65 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 66 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 67 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 68 |
Insulin Analog [EPC] |
2 |
0.0000 |
| 69 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 70 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 71 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |